Filing Flows › Ironwood Pharmaceuticals (IRWD) › Q1 2026
Ironwood Pharmaceuticals (IRWD) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Ironwood Pharmaceuticals (IRWD) reported revenue of $107M for the first quarter 2026 (Q1 2026), +159% from a year earlier and +123% from the quarter before. Operating margin was 68.1%, net earnings $40.8M (38.3% of revenue).
Ironwood Pharmaceuticals, Q1 2026: revenue $107M (+159% year over year), operating margin 68.1%, net earnings $40.8M, operating cash flow $5.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $107M | +123% | +159% |
| Operating profit | $72.6M | +966% | — |
| Net earnings | $40.8M | — | — |
| Operating cash flow | $5.1M | -93% | -74% |
What changed
Revenue was $106.5M in Q1 2026, up 159% year over year and up 123% from the previous quarter.
Operating profit was $72.6M, a 68.1% margin (up 138.9 points year over year). Total costs fell 52% while revenue rose 159%. Net earnings were $40.8M. The effective tax rate was 37.4%.
Operating cash flow was $5.1M (down 74% year over year), 13% of net earnings. Non-cash charges added back $443K of depreciation and $3.7M of share-based compensation. Working capital and other items used $39.7M.
Questions
What was Ironwood Pharmaceuticals' revenue in the first quarter 2026?
Ironwood Pharmaceuticals (IRWD) reported revenue of $107M for the first quarter 2026 (Q1 2026), +159% from a year earlier and +123% from the quarter before.
Was Ironwood Pharmaceuticals profitable in the first quarter 2026?
Operating profit was $72.6M (68.1% of revenue) and net earnings $40.8M.